Electroporation is a physical method for delivery of various molecules, such as chemothera-peutic drugs and plasmid DNA into the cells by transiently increasing permeability of the cell membrane using application of controlled external field to the cells. Electrochemotherapy is anticancer treatment that utilizes electroporation of cells to increase chemotherapeutic drug uptake, specifically at the site where electric pulses are applied. Suitable chemotherapeutic drugs for electro-chemotherapy are those with hampered transport through the plasma membrane, such as bleomycin and cisplatin. Preclinical studies have demonstrated good antitumor effectiveness of electrochemother-apy with bleomycin and cisplatin, given either intravenously or intratumorally, on different tumor and animal models. Besides antitumor effectiveness, minimal toxicity and safety of the procedure were demonstrated. Clinical studies using electrochemotherapy for treatment of cutaneous and subcutaneous tumors of different histology have demonstrated pronounced antitumor effectiveness with ~ 85% objective responses of the treated tumors. Electrochemotherapy is a new, clinically ac -knowledged method for the treatment of cutaneous and subcutaneous tumor nodules. The advantage of this therapy is its high effectiveness on tumors of different histology, simple application, minimal side effects, and the possibility of effective repetitive treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Andre F, Mir LM. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther. 2004;11(Suppl 1):S33– 42
Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cells and tissues assessed by the quantitative and qualitative electroloading of bleomycin. Biochim Biophys Acta. 1994;1190:155– 63
Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol. 2005;31:1029– 35
Byrne CM, Thompson JF, Johnston H, Hersey P, Quinn MJ, Hughes M, McCarthy WH. Treatment of metastatic melanoma using electroporation therapy with bleomycin (elec-trochemotherapy). Melanoma Res. 2005;15:45– 51
Byrne CM, Thompson JF. Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev Anticancer Ther. 2006;6:671– 8
Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G. Intratumoral cisplatin administration in electrochemother-apy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs. 1998;9:525– 30
Cemazar M, Golzio M, Sersa G, Rols MP, Teissie J. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des. 2006;12:3817– 25
Cemazar M, Sersa G. Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther. 2007;9:554– 62
Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie T. Electrochemotherapy in veterinary oncology. J Vet Int Med. 2008;22:826– 31
Domenge C, Orlowski S, Luboinski B, De Baere T, Belehradek J Jr, Mir LM. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 1996;77:956– 63
Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta. 2002; 1569:51– 8
Gehl J, Geertsen PF. Palliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy. EJC Suppl. 2006;4:35– 7
Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti R, Fenske NA, Gilbert RA, Mir LM, Reintgen DS. Phase I/II trial for treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996; 77:964– 71
Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 1997;7:10– 8
Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, Glaas LF. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148– 57
Heller R, Gilbert R, Jaroszeski MJ. Clinical applications of electrochemotherapy. Adv Drug Deliver Rev. 1999;35:119– 29
Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther. 2006;17:890– 7
Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Soden DM, Rudolf Z, Robert C, O' Sullivan GC, Mir LM. Electrochemotherapy — an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl. 2006;4:3– 13
Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl. 2006;4: 45– 51
Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J, Schwaab G, Luboinski B, Paoletti C. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III. 1991;313:613– 8
Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, Belehradek M, Gilbert R, Rols MP, Belehradek J Jr, Bachaud JM, DeConti R, Stabuc B, Cemazar M, Coninx P, Heller R. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 1998;77:2336– 42
Mir LM. Bases and rationale of the electrochemotherapy. EJC Suppl. 2006;4:38– 44
Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen P, Rudolf Z, O' Sullivan GC, Marty. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either sys-temically or locally and electric pulses delivered by the Cliniporator ™ by means of invasive or non-invasive electrodes. EJC Suppl. 2006;4:14– 25
Neumann E, Schaefer-Ridder M, WangY, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982;1:841– 5
Puc M, Corovic S, Flisar K, Petkovsek M, Nastran J, Miklavcic D. Techniques of signal generation required for electropermeabilization: survey of electropermeabilization devices. Bioelectrochem. 2004;64:113– 24
Sarnaik AA, Zager JS, Sondak VK. Multidisciplinary management of special melanoma situations: oligometastatic disease and bulky nodal sites. Curr Oncol Rep. 2007; 9:417– 27
Sersa G, Miklavcic D, Cemazar M, Belehradek J Jr, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocom-petent and immunodeficient mice. Bioelectroch Bioener. 1997;43:279– 83
Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer. 1998; 34:1213– 8
Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer. 1999;35:672– 7
Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res. 2000;6:863– 7
Sersa G. The state-of-the-art of electrochemotherapy before the ESOPE study: advantages and clinical uses. EJC Suppl. 2006;4:52– 9
Sersa G, Cemazar M, Miklavcic D, Rudolf Z. Electrochemo-therapy of tumours. Radiol Oncol. 2006;40:163– 74
Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M. Vascular disrupting action of electroporation and electro-chemotherapy with bleomycin in murine sarcoma. Brit J Cancer. 2008;98:388– 98
Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. EJSO. 2008;34:232– 40
Snoj M, Rudolf Z, Cemazar M, Jancar B, Sersa G. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. AntiCancer Drugs. 2005; 16:345– 8
Snoj M, Rudolf Z, Paulin-Kosir S, Cemazar M, Snoj R, Sersa G. Long lasting complete response in melanoma treated by electrochemotherapy. EJC Suppl. 2006;4: 26– 8
Snoj M, Cemazar M, Slekovec Kolar B, Sersa G. Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy: case report. Croat Med J. 2007;48:391– 5
Acknowledgments
The author gratefully acknowledges finan-cial support from the state budget of the Slovenian Research Agency and the European Commission' s ESOPE project (QLK-2002– 02003), funded under the 5th Framework Program
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sersa, G. (2010). Electrochemotherapy in Treatment of Cutaneous Tumors. In: Jemec, G.B.E., Kemeny, L., Miech, D. (eds) Non-Surgical Treatment of Keratinocyte Skin Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79341-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-540-79341-0_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79340-3
Online ISBN: 978-3-540-79341-0
eBook Packages: MedicineMedicine (R0)